SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION
SIREN : 314210626
Employees: 22 (2023.0)Legal category: SA (autres)Size: ETICreation date: 1978-01-01 (48 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: SAINT-PIERRE (97410), La Reunion
SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION : revenue, balance sheet and financial ratios
SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION is a French company
founded 48 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in SAINT-PIERRE (97410),
this company of category ETI
shows in 2024 a revenue of 112.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION (SIREN 314210626)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue
112 628 440 €
99 795 701 €
92 340 276 €
84 947 356 €
76 934 924 €
72 947 093 €
68 838 380 €
63 093 636 €
59 658 022 €
56 210 007 €
Net income
1 740 910 €
1 047 878 €
2 066 988 €
1 287 912 €
510 997 €
924 329 €
1 029 760 €
911 805 €
1 144 116 €
946 333 €
EBITDA
3 523 103 €
2 734 231 €
2 493 886 €
3 429 213 €
1 509 937 €
2 289 694 €
2 332 807 €
1 805 269 €
2 304 231 €
1 764 620 €
Net margin
1.5%
1.1%
2.2%
1.5%
0.7%
1.3%
1.5%
1.4%
1.9%
1.7%
Revenue and income statement
In 2024, SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION achieves revenue of 112.6 M€. Over the period 2015-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +8.0%. Vs 2023, growth of +13% (99.8 M€ -> 112.6 M€). After deducting consumption (94.8 M€), gross margin stands at 17.9 M€, i.e. a rate of 16%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 3.5 M€, representing 3.1% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 1.7 M€, i.e. 1.5% of revenue. This profit can be retained or distributed to shareholders.
Revenue (2024)
?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production
112 628 440 €
Gross margin (2024)
?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed
17 854 804 €
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
3 523 103 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
3 161 351 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
1 740 910 €
EBITDA margin (2024)
?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability 5-10% : Average < 5% : Low
3.1%
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 79%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 27%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 4.1 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 1.8% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
79.114%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
26.956%
Cash flow / Revenue (2024)
?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates
1.844%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
4.106
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
121.485
114.162
88.078
63.221
49.401
127.276
83.193
67.315
66.339
79.114
Financial autonomy
22.783
21.888
22.636
29.18
29.944
22.328
24.943
27.676
28.724
26.956
Repayment capacity
0.698
1.242
0.0
1.351
1.241
7.055
1.786
2.207
2.813
4.106
Cash flow / Revenue
1.69%
2.225%
1.987%
1.976%
1.598%
1.124%
2.431%
2.093%
1.396%
1.844%
Sector positioning
Debt ratio
79.112024
2022
2023
2024
Q1: 0.0
Med: 4.27
Q3: 43.96
Average
In 2024, the debt ratio of SOCIETE DE CONDITIONNEMEN... (79.11) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
26.96%2024
2022
2023
2024
Q1: 14.64%
Med: 38.36%
Q3: 60.56%
Average
In 2024, the financial autonomy of SOCIETE DE CONDITIONNEMEN... (27.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
4.11 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 1.09 years
Average
In 2024, the repayment capacity of SOCIETE DE CONDITIONNEMEN... (4.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 188.57. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 13.5x. Operating income very largely covers interest expenses: high safety margin.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
188.575
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
13.486
Liquidity indicators evolution SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
125.961
130.049
122.393
152.482
148.694
169.561
151.192
159.684
161.101
188.575
Interest coverage
23.761
13.274
11.485
16.268
16.616
22.673
10.382
14.81
18.548
13.486
Sector positioning
Liquidity ratio
188.572024
2022
2023
2024
Q1: 132.74
Med: 202.27
Q3: 325.9
Average+12 pts over 3 years
In 2024, the liquidity ratio of SOCIETE DE CONDITIONNEMEN... (188.57) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
13.49x2024
2022
2023
2024
Q1: 0.0x
Med: 0.41x
Q3: 6.25x
Excellent
In 2024, the interest coverage of SOCIETE DE CONDITIONNEMEN... (13.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 20 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 46 days. Favorable situation: supplier credit is longer than customer credit by 26 days. Inventory turnover is 88 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 97 days of revenue, i.e. 30.5 M€ to permanently finance. Over 2015-2024, WCR increased by +31%, requiring additional financing.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
30 496 403 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
20 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
46 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
88 j
WCR in days of revenue (2024)
?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management
97 j
WCR and payment terms evolution SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
23 236 655 €
25 442 357 €
24 087 257 €
19 172 177 €
21 308 575 €
23 918 299 €
24 404 526 €
26 414 859 €
25 135 543 €
30 496 403 €
Inventory turnover (days)
70
74
76
73
89
96
94
98
85
88
Customer payment term (days)
22
17
14
28
25
24
24
20
18
20
Supplier payment term (days)
79
85
85
52
56
51
54
50
44
46
Positioning of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION is estimated at
8 722 059 €
(range 4 597 297€ - 27 354 545€).
With an EBITDA of 3 523 103€, the sector multiple of 0.7x is applied.
The price/revenue ratio is 0.21x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
124 transactions
4597k€8722k€27354k€
8 722 059 €Range: 4 597 297€ - 27 354 545€
NAF 5 all-time
Valuation detail by method
Ajustez les pondérations selon votre analyse
EBITDA Multiple50%
3 523 103 €×0.7x
Estimation2 479 860 €
1 172 318€ - 9 025 785€
Revenue Multiple30%
112 628 440 €×0.21x
Estimation23 986 974 €
13 007 568€ - 72 656 940€
Net Income Multiple20%
1 740 910 €×0.8x
Estimation1 430 185 €
544 339€ - 5 222 854€
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION with other companies in the same sector:
Frequently asked questions about SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION
What is the revenue of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION ?
The revenue of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION in 2024 is 112.6 M€.
Is SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION profitable?
Yes, SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION generated a net profit of 1.7 M€ in 2024.
Where is the headquarters of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION ?
The headquarters of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION is located in SAINT-PIERRE (97410), in the department La Reunion.
Where to find the tax return of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION ?
The tax return of SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION operate?
SOCIETE DE CONDITIONNEMENT ET DE DISTRIBUTION DE PRODUITS PHARMACEUTIQUES DE LA REUNION operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart